Literature DB >> 6861121

Ketone body, glucose, lactic acid, and amino acid utilization by tumors in vivo in fasted rats.

L A Sauer, R T Dauchy.   

Abstract

Arteriovenous differences for acetoacetate, beta-hydroxybutyrate, glucose, lactic acid, and glutamine and other amino acids were measured across Morris hepatomas 5123C, 7777, and 7288CTCF and Walker sarcocarcinoma 256 in vivo in rats fasted for 2 days. The acetoacetate and beta-hydroxybutyrate concentrations in arterial whole blood of fasted tumor-bearing rats were 0.52 +/- 0.06 and 1.82 +/- 0.19 mM (S.E., n = 38), respectively. Both ketone bodies were utilized by the tumors, and the rates of utilization were directly related to the rates of supply. The mean utilization rates for acetoacetate and beta-hydroxybutyrate were 13.9 +/- 2.9 (range, 0 to 64; n = 30) and 24.7 +/- 4.4 (range, 0 to 145; n = 38) nmol/min/g tumor wet weight, respectively. Eight of the tumors produced acetoacetate, presumably from utilized beta-hydroxybutyrate. An average of 52% of the acetoacetate and 30% of the beta-hydroxybutyrate carried in the arterial blood was removed during one pass through the tumors. The concentrations of glucose and glutamine in the arterial whole blood of fasted tumor-bearing rats (n = 38) were 6.55 +/- 0.3 and 0.76 +/- 0.02 mM, respectively; both of these substrates were utilized at rates that were directly proportional to the rates of supply. The mean rates of glucose and glutamine utilization for all tumors in fasted rats were 101 +/- 11 (range, 3 to 313) and 8.2 +/- 1.1 (range, 0 to 25.1) nmol/min/g tumor wet weight, respectively. Thirty-six % of the glucose and 25% of the glutamine supplied to the tumors was utilized. Comparison (by linear regression and analysis of covariance) of the rates of supply and utilization of glucose and glutamine in tumors growing in fasted versus fed rats indicated that these substrates are utilized more efficiently by tumors growing in fasted animals. Lactic acid was either produced or utilized, depending on the arterial whole-blood concentration. Production or utilization occurred, respectively, when the arterial lactate concentration was less or greater than 1 to 3 mM. The arterial whole-blood amino acids (except glutamine) were utilized at rates that ranged from 1 to 4 nmol/min/g tumor wet weight. The results indicate that energy production for tumor growth in fasted rats is supported, in part, by an increased availability of ketone bodies, by an increased efficiency of utilization of glucose and glutamine, and, under certain circumstances, by utilization of lactic acid.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6861121

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

Review 1.  Relevance of glutamine metabolism to tumor cell growth.

Authors:  M A Medina; F Sánchez-Jiménez; J Márquez; A Rodríguez Quesada; I Núñez de Castro
Journal:  Mol Cell Biochem       Date:  1992-07-06       Impact factor: 3.396

Review 2.  The Tumor Metabolic Microenvironment: Lessons from Lactate.

Authors:  Juan C García-Cañaveras; Li Chen; Joshua D Rabinowitz
Journal:  Cancer Res       Date:  2019-06-06       Impact factor: 12.701

3.  Adaptive alterations in cellular metabolism with malignant transformation.

Authors:  C P Fischer; B P Bode; W W Souba
Journal:  Ann Surg       Date:  1998-05       Impact factor: 12.969

4.  To diet or not to diet - that is still the question.

Authors:  Johannes Rieger; Joachim P Steinbach
Journal:  Neuro Oncol       Date:  2016-08       Impact factor: 12.300

Review 5.  Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation.

Authors:  Kelly M Kennedy; Mark W Dewhirst
Journal:  Future Oncol       Date:  2010-01       Impact factor: 3.404

6.  [11C] acetoacetate utilization by breast and prostate tumors: a PET and biodistribution study in mice.

Authors:  Simon Authier; Sébastien Tremblay; Véronique Dumulon; Céléna Dubuc; René Ouellet; Roger Lecomte; Stephen C Cunnane; François Bénard
Journal:  Mol Imaging Biol       Date:  2008-05-03       Impact factor: 3.488

Review 7.  Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer.

Authors:  R J DeBerardinis; T Cheng
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

Review 8.  Glutamine as indispensable nutrient in oncology: experimental and clinical evidence.

Authors:  Katharina S Kuhn; Maurizio Muscaritoli; Paul Wischmeyer; Peter Stehle
Journal:  Eur J Nutr       Date:  2009-11-21       Impact factor: 5.614

9.  RhoC GTPase Is a Potent Regulator of Glutamine Metabolism and N-Acetylaspartate Production in Inflammatory Breast Cancer Cells.

Authors:  Michelle L Wynn; Joel A Yates; Charles R Evans; Lauren D Van Wassenhove; Zhi Fen Wu; Sydney Bridges; Liwei Bao; Chelsea Fournier; Sepideh Ashrafzadeh; Matthew J Merrins; Leslie S Satin; Santiago Schnell; Charles F Burant; Sofia D Merajver
Journal:  J Biol Chem       Date:  2016-04-25       Impact factor: 5.157

Review 10.  Glutamine and cancer.

Authors:  W W Souba
Journal:  Ann Surg       Date:  1993-12       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.